The researchers are focusing on the lung-mucus barrier, the first line of defense against inhaled viruses.
The researchers are focusing on the lung-mucus barrier, the first line of defense against inhaled viruses.
As the spread of the coronavirus forced hospitals to reduce visitors, a team at UNC Health worked to connect patients and their loved ones virtually.
In the first COVID-19 case series of tocilizumab in the United States, Carolina researchers and students report that the drug tocilizumab should be used judiciously until randomized clinical trials determine the drug’s true efficacy for severely ill patients.
Through the UNC Frank Porter Graham Child Development Institute’s Program on Mindfulness and Self-Compassion for Families, Karen Bluth is helping teens address their anxiety and stress.
The coloring book was created to help children cope with the many stresses and challenges stemming from the COVID-19 pandemic.
Remdesivir was developed through an academic-corporate partnership between Gilead Sciences and the Baric Lab at the UNC Gillings School of Global Public Health.
